Michael Schmidt will join Guggenheim Securities in June as a senior analyst and senior managing director as part of the company's expansion of its healthcare research team.

Schmidt will focus on the coverage of biotech companies and will work closely with its therapeutics team.

He has served as an equity research analyst at LEERINK Partners since 2009.

Guggenheim Securities is the investment banking and capital markets division of Guggenheim Partners.